Literature DB >> 10567728

Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans.

O T Wolf1, C Kirschbaum.   

Abstract

Dehydroepiandrosterone (DHEA) and its sulfate ester, DHEAS, exert multiple effects in the rodent central nervous system (CNS). Most of them seem to be mediated through their non-genomic action on several neurotransmitter receptors. DHEA(S) increases neuronal excitability, enhances neuronal plasticity and also has neuroprotective properties. In line with these observations DHEA(S) treatment in rodents enhances memory in several paradigms. Even more studies show antiamnestic effects of the steroids. However, DHEA(S) has also anxiolytic and anti-aggressive properties. In humans cross-sectional and longitudinal studies suggest that DHEAS might be associated with global measures of well-being and functioning; however, a relationship with cognition could not be detected to date. Moreover, studies investigating DHEAS levels in neurodegenerative diseases have produced conflicting results. Experimental studies in elderly humans have revealed preliminary evidence for mood enhancing and antidepressant effects of DHEA treatment, while positive effects on measures of memory and attention could not be found. However, electrophysiological studies demonstrated that DHEA treatment has effects on the human CNS. Several reasons for the discrepancy between data obtained in rodents and humans are discussed and research perspectives are outlined which might help to improve interpretation of results obtained in the two species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567728     DOI: 10.1016/s0165-0173(99)00021-1

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  40 in total

Review 1.  The Adaptive Calibration Model of stress responsivity.

Authors:  Marco Del Giudice; Bruce J Ellis; Elizabeth A Shirtcliff
Journal:  Neurosci Biobehav Rev       Date:  2010-12-08       Impact factor: 8.989

2.  Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain.

Authors:  Emily D Salman; Ona Faye-Petersen; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2011-10

3.  Treatment with dehydroepiandrosterone (DHEA) stimulates oxidative energy metabolism in the liver mitochondria from developing rats.

Authors:  Minal A Patel; Surendra S Katyare
Journal:  Mol Cell Biochem       Date:  2006-06-23       Impact factor: 3.396

4.  Perimenopausal regulation of steroidogenesis in the nonhuman primate.

Authors:  Krystina G Sorwell; Steven G Kohama; Henryk F Urbanski
Journal:  Neurobiol Aging       Date:  2011-06-17       Impact factor: 4.673

Review 5.  Role of circadian neuroendocrine rhythms in the control of behavior and physiology.

Authors:  Henryk F Urbanski
Journal:  Neuroendocrinology       Date:  2011-04-21       Impact factor: 4.914

Review 6.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

Review 7.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  A review of coumarin derivatives in pharmacotherapy of breast cancer.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 9.  Androgen therapy with dehydroepiandrosterone.

Authors:  Jacques Buvat
Journal:  World J Urol       Date:  2003-10-10       Impact factor: 4.226

10.  Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.

Authors:  William Davies; Trevor Humby; Wendy Kong; Tamara Otter; Paul S Burgoyne; Lawrence S Wilkinson
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.